|
Company secretary's report.
Journal of the Australian Traditional-MedicineSociety
|
September 1, 2008|
|
COPYRIGHT 2008 Australian Traditional-Medicine Society. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
The Times they are a-changing.
--Bob Dylan, 1964.
Hello
Welcome everyone to the first report by an ATMS Company Secretary that is not being written by the redoubtable Marie Fawcett. As you read in the last issue of the Journal of the Australian Traditional-Medicine Society, Marie has decided to take a very well-earned retirement.
ATMS Is Its Members
|
Procyon BioPharma Inc.: Annual General and Special Meeting - Advances in Financing, Product Development and Partnerships.
News Wire article from: Canadian Corporate News
; ...CCN Disclosure, November 16, 2000) Procyon BioPharma Inc. held its annual general...marked an important new direction for Procyon in its development. Our move to Montreal...Partnership Highlights This year, Procyon finalized several important partnerships...
|
|
Procyon Announces the Completion of the Acquisition of Cellpep S.A. and the Concurrent Private Placement.
Business Wire
; MONTREAL -- Procyon Biopharma Inc. ("Procyon") (TSX:PBP) - Procyon changes its corporate name to Ambrilia Biopharma Inc. - Ticker symbol PBP on the Toronto Stock Exchange to change to AMB on March 3, 2006 ATTENTION BUSINESS/FINANCIAL...
|
|
Procyon Announces Receipt for Short Form Prospectus
Newspaper article from: CCNMatthews Newswire
; ...CCNMatthews - Feb. 22, 2006) - Procyon Biopharma Inc. (TSX:PBP) Not for...BUSINESS/FINANCIAL/HEALTH EDITORS Procyon Biopharma Inc., a biotechnology company...concurrent to the merger via acquisition of Procyon and Cellpep S.A. The short form prospectus...
|
|
|
Procyon Demonstrates Progress on Anticancer Technologies at Annual Meeting of American Association for Cancer Research (AACR).
News Wire article from: Canadian Corporate News
; MONTREAL, QUEBEC, APR 9, 2001 Procyon BioPharma Inc. ("Procyon") announced that results from preclinical studies...platform technologies further validate the potential of Procyon platform technologies as anti-cancer treatments...
|
|
|
Procyon BioPharma Inc. : Innovative Product to Reduce Severe Scars From Surgery and Burns, Procyon BioPharma Inc. Announces IND Application for Fibrostat (R) Clinical Study.
News Wire article from: Canadian Corporate News
; ...QUEBEC--(CCN Disclosure, December 21, 2000) Procyon BioPharma Inc. ("Procyon") announced today that an IND (investigational...surgery and burns. The application was filed by Procyon's development partner, Crystaal, the Canadian...
|
|
|
Procyon Announces the Completion of the Acquisition of Cellpep S.A. and the Concurrent Private Placement
Newspaper article from: CCNMatthews Newswire
; MONTREAL, QUEBEC--(CCNMatthews - March 1, 2006) - Procyon Biopharma Inc. ("Procyon") (TSX:PBP) -__ Procyon changes its corporate name to Ambrilia Biopharma Inc. -__ Ticker symbol PBP on the Toronto...
|
|
|
Procyon and Cellpep to Merge Via Acquisition Creating a New Global Biopharmaceutical Company: Ambrilia Biopharma Inc.
News Wire article from: Canadian Corporate News
; ...2006 (CCNMatthews via COMTEX) -- Procyon Biopharma Inc. (TSX:PBP) ATTENTION...Montreal with a regional office in France Procyon Biopharma Inc., a biotechnology company...definitive acquisition agreement under which Procyon has offered to acquire all of the outstanding...
|
|
|
Procyon's Shareholders Approve Merger Via Acquisition with Cellpep S.A.
News Wire article from: Canadian Corporate News
; ...2006 (CCNMatthews via COMTEX) -- Procyon Biopharma Inc. (TSX:PBP), a biotechnology...Shareholders held today, shareholders of Procyon approved the acquisition of Cellpep S...warrants and units. The name change of Procyon Biopharma Inc. to Ambrilia Biopharma...
|
|
Procyon Biopharma identifies novel PSP94 binding protein.
PR Newswire
; ...detection and prognosis of prostate cancer Procyon Biopharma Inc. (TSX:PBP) announced...binding protein, a crucial part of Procyon's assay development technology for prostate...previous peer-reviewed publication, Procyon's collaborating scientists demonstrated...
|
|
PROCYON CUTS JOBS, CLOSES LABS TO REDUCE CASH FLOW.(Procyon Biopharma Inc. )
Magazine article from: BIOWORLD Today
; ...Byline: Jennifer Boggs, Staff Writer Procyon Biopharma Inc. will cut a third of its...said Hans Mader, president and CEO of Procyon. "We all expected that the Phase IIb...C$12 million for our 2005 budget." Procyon reported Jan. 18 that Fibrostat, a topical...
|
Find more facts and information related to the
article "Company secretary's report."
